May 26, 2025 | 2025, Investors, Press Releases
More detailsMay 6, 2025 | 2025, Investors, Press Releases
more detailsApr 29, 2025 | 2025, Investors, Press Releases
more detailsApr 23, 2025 | 2025, Events, Past Events, Scientific
Claudia Comacchio is presenting a poster about Philochem’s ACP3 antibody therapeutics on April 29, entitled “Generation and in vivo characterization of a novel antibody targeting Prostatic Acid Phosphatase (ACP-3)” [Abstract Number 4781]. Gudrun Thorhallsdottir is...Apr 23, 2025 | 2025, Events, Past Events, Scientific
Dr. Sebastian Oehler will present Philochem’s recent discovery in the field of prostate cancer under the title “From DNA-Encoded Chemistry to ACP3-Targeted Radioligand Therapeutics against Prostate Cancer” on May 13th (Radiopharmaceutical Therapies track). Follow the...Apr 23, 2025 | 2025, Events, Past Events, Scientific
Dr. Philipp Backhaus is giving a presentation entitled “A new theranostic target in prostate cancer: First results from prostatic acid phosphatase (ACP3) imaging with [68Ga]Ga-OncoACP3-DOTA PET in prostate cancer patients and comparison to [18F]F-PSMA-1007” about the...
Recent Comments